Integrating Combined Therapies for Persons with Co-occurring Disorders
对患有并发疾病的人进行综合治疗
基本信息
- 批准号:9415334
- 负责人:
- 金额:$ 17.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-30 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Persons with alcohol use disorders are three times more likely to have a co-occurring psychiatric disorder than those without alcohol use diagnoses. Co-occurring alcohol and psychiatric disorders are highly prevalent in clinical settings and, relative to those with a single disorder alone, these patients have more challenging treatment and recovery experiences. Integrated treatments result in more favorable outcomes, yet these services are not widely available. This is a revised R21 application, "Integrating combined therapies for persons with co-occurring disorders." We propose to evaluate an integrated adaptation of the Combined Behavioral Intervention (CBI) from NIAAA Project COMBINE. CBI features three evidence-based behavioral therapies: Motivational Enhancement Therapy (MET), Cognitive Behavioral Therapy (CBT) and Twelve Step Facilitation Therapy (TSF). We adapted CBI into a novel manual-guided intervention for co-occurring psychiatric and substance-related problems. Integrating Combined Therapies (ICT) is an individual-format treatment designed to be transferable to routine care settings and for delivery by the existing workforce. A small pilot study supported the clinical promise of ICT as well as its safety and practicality. In the research now proposed, we will randomly assign 76 eligible patients in community outpatient addiction treatment to ICT adapted standard care versus standard care only. Primary outcomes will be assessed at baseline, 3-, and 6- month follow-up periods. We hypothesize that ICT adapted standard care will demonstrate improved alcohol, drug and psychiatric outcomes, and that ICT participants will have better retention in treatment services. As found in our preliminary research, we also expect typical program counselors to be able to deliver ICT with satisfactory adherence and competence. The gap between the discovery and routine delivery of evidence-based treatments for alcohol use disorders is substantial. This problem is compounded when one considers the disparity in public access to efficacious integrated services for persons with co-occurring substance use and psychiatric disorders. The present research stands to address this issue, by rigorously evaluating a promising and community- friendly option for a broad spectrum psychosocial therapy. If found to be effective in this trial, the next logical research steps would be further efficacy study of ICT in a larger randomized controlled trial, as well as in dismantling and fractional factorial designs. The overarching goal of this research is to contribute to better treatment and recovery outcomes for individuals with co-occurring disorders.
描述(由申请人提供):患有酒精使用障碍的人患有并发精神疾病的可能性是没有酒精使用诊断的人的三倍。同时发生的酒精和精神疾病在临床环境中非常普遍,相对于那些单独患有单一疾病的患者,这些患者的治疗和恢复经历更具挑战性。综合治疗会产生更有利的结果,但这些服务并不普遍。这是一个修订后的R21应用程序,“整合合并疾病的人的联合治疗。“我们建议评估NIAAA项目联合收割机的联合行为干预(CBI)的综合适应性。CBI有三种循证行为疗法:动机增强疗法(MET),认知行为疗法(CBT)和十二步促进疗法(TSF)。我们将CBI改编为一种新的手动指导干预,用于同时发生的精神病和物质相关问题。整合联合疗法(ICT)是一种个体形式的治疗,旨在转移到常规护理环境中,并由现有的劳动力提供。一项小型试点研究支持ICT的临床承诺及其安全性和实用性。在现在提出的研究中,我们将随机分配76名符合条件的社区门诊成瘾治疗患者接受ICT适应性标准治疗与仅接受标准治疗。将在基线、3个月和6个月随访期评估主要结局。我们假设,信息和通信技术适应的标准治疗将证明改善酒精,药物和精神疾病的结果,信息和通信技术的参与者将有更好的保留在治疗服务。正如我们在初步研究中发现的那样,我们还希望典型的项目辅导员能够以令人满意的坚持和能力提供信息和通信技术。酒精使用障碍循证治疗的发现和常规治疗之间存在着巨大的差距。如果考虑到同时患有药物使用和精神疾病的人在获得有效综合服务方面的差距,这一问题就更加复杂了。目前的研究旨在解决这个问题,通过严格评估一个有前途的和社区友好的选择,为广谱心理社会治疗。如果在本试验中发现有效,接下来的逻辑研究步骤将是在更大的随机对照试验中以及在拆卸和部分析因设计中进一步研究ICT的有效性。这项研究的总体目标是为患有并发症的个体提供更好的治疗和康复结果。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The expanding role of electrospray ionization mass spectrometry for probing reactive intermediates in solution.
电喷雾电离质谱在探测溶液中的反应中间体方面的扩展作用
- DOI:10.3390/molecules171011507
- 发表时间:2012-09-27
- 期刊:
- 影响因子:0
- 作者:Zhu W;Yuan Y;Zhou P;Zeng L;Wang H;Tang L;Guo B;Chen B
- 通讯作者:Chen B
Effects of Prunella vulgaris on the mice immune function.
- DOI:10.1371/journal.pone.0077355
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Huang R;Zhao M;Yang X;Huang J;Yang Y;Chen B;Tan J;Huang J;Li Z;Lv Y;Ji G
- 通讯作者:Ji G
Effects of Malania oleifera Chun Oil on the Improvement of Learning and Memory Function in Mice.
- DOI:10.1155/2020/8617143
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Wu R;Zhong S;Ni M;Zhu X;Chen Y;Chen X;Zhang L;Chen J
- 通讯作者:Chen J
Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer.
- DOI:10.1371/journal.pone.0035957
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Du J;Zhou N;Liu H;Jiang F;Wang Y;Hu C;Qi H;Zhong C;Wang X;Li Z
- 通讯作者:Li Z
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark P McGovern其他文献
Mark P McGovern的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark P McGovern', 18)}}的其他基金
Center for Dissemination and Implementation At Stanford (C-DIAS)
斯坦福大学传播与实施中心 (C-DIAS)
- 批准号:
10493956 - 财政年份:2022
- 资助金额:
$ 17.31万 - 项目类别:
Center for Dissemination and Implementation At Stanford (C-DIAS): Administrative Core
斯坦福大学传播和实施中心 (C-DIAS):行政核心
- 批准号:
10493957 - 财政年份:2022
- 资助金额:
$ 17.31万 - 项目类别:
Center for Dissemination and Implementation At Stanford (C-DIAS): Administrative Core
斯坦福大学传播与实施中心 (C-DIAS):行政核心
- 批准号:
10668468 - 财政年份:2022
- 资助金额:
$ 17.31万 - 项目类别:
Center for Dissemination and Implementation At Stanford (C-DIAS)
斯坦福大学传播与实施中心 (C-DIAS)
- 批准号:
10668467 - 财政年份:2022
- 资助金额:
$ 17.31万 - 项目类别:
Integrated CBT for Co-Occurring PTSD and Substance Use Disorders
针对同时发生的 PTSD 和药物滥用障碍的综合 CBT
- 批准号:
8494028 - 财政年份:2010
- 资助金额:
$ 17.31万 - 项目类别:
Integrated CBT for Co-Occurring PTSD and Substance Use Disorders
针对同时发生的 PTSD 和药物滥用障碍的综合 CBT
- 批准号:
8132471 - 财政年份:2010
- 资助金额:
$ 17.31万 - 项目类别:
Integrated CBT for Co-Occurring PTSD and Substance Use Disorders
针对同时发生的 PTSD 和药物滥用障碍的综合 CBT
- 批准号:
8282721 - 财政年份:2010
- 资助金额:
$ 17.31万 - 项目类别:
A Stage II Efficacy Study of CBT for PTSD in Community Addiction Treatment
CBT 在社区成瘾治疗中治疗 PTSD 的 II 期疗效研究
- 批准号:
8263983 - 财政年份:2010
- 资助金额:
$ 17.31万 - 项目类别:
相似海外基金
Novel nanotechnology strategies for drug co-delivery and combined therapies in the brain
用于大脑药物共同递送和联合治疗的新型纳米技术策略
- 批准号:
nhmrc : 1194825 - 财政年份:2020
- 资助金额:
$ 17.31万 - 项目类别:
Investigator Grants
Crucial spinal circuit changes that mediate locomotion benefits of combined biological/bionic/rehabilitation therapies after spinal cord injury.
脊髓损伤后联合生物/仿生/康复治疗的关键脊髓回路变化可调节运动益处。
- 批准号:
10213148 - 财政年份:2018
- 资助金额:
$ 17.31万 - 项目类别:
Combined Regenerative and Rehabilitation Therapies for Extremity Trauma
四肢创伤的再生与康复联合疗法
- 批准号:
10724267 - 财政年份:2018
- 资助金额:
$ 17.31万 - 项目类别:
Combined Regenerative and Rehabilitation Therapies for Extremity Trauma
四肢创伤的再生与康复联合疗法
- 批准号:
10259685 - 财政年份:2018
- 资助金额:
$ 17.31万 - 项目类别:
Combined Regenerative and Rehabilitation Therapies for Extremity Trauma
四肢创伤的再生与康复联合疗法
- 批准号:
9816580 - 财政年份:2018
- 资助金额:
$ 17.31万 - 项目类别:
Crucial spinal circuit changes that mediate locomotion benefits of combined biological/bionic/rehabilitation therapies after spinal cord injury.
脊髓损伤后联合生物/仿生/康复治疗的关键脊髓回路变化可调节运动益处。
- 批准号:
10447027 - 财政年份:2018
- 资助金额:
$ 17.31万 - 项目类别:
Combined Regenerative and Rehabilitation Therapies for Extremity Trauma
四肢创伤的再生与康复联合疗法
- 批准号:
10723190 - 财政年份:2018
- 资助金额:
$ 17.31万 - 项目类别:
Combined Stem Cell and Rehabilitation Therapies for Osteoarthritis
骨关节炎的干细胞与康复疗法相结合
- 批准号:
9350659 - 财政年份:2017
- 资助金额:
$ 17.31万 - 项目类别:
Combined Nanoparticle and Neural Stem Cell Therapies in a Pig Model of Stroke
纳米颗粒和神经干细胞联合疗法在猪中风模型中的应用
- 批准号:
9147015 - 财政年份:2015
- 资助金额:
$ 17.31万 - 项目类别:
Development of the combined immune-modulatory therapies for canine cancer
犬癌症联合免疫调节疗法的开发
- 批准号:
15H04598 - 财政年份:2015
- 资助金额:
$ 17.31万 - 项目类别:
Grant-in-Aid for Scientific Research (B)